Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets

Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets Specification

Dosage Form
Solid

Origin of Medicine
India

Drug Type
General Medicines

Physical Form
Tablets

Dosage
50mg, 200mg and 25mg

Storage Instructions
Dry Place

Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets Trade Information

Minimum Order Quantity
100 Bottles

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Bottles Per Month

Delivery Time
2-7 Days

Main Domestic Market
All India

About Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets

Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets are a type of general medicine that originated in India. These tablets come in a solid dosage form and are available in three different doses of 50mg, 200mg, and 25mg. The tablets are designed to be stored in a dry place to maintain their efficacy. The tablets contain a combination of active ingredients that work together to treat human immunodeficiency virus (HIV) infection. Dolutegravir is an integrase strand transfer inhibitor that prevents the virus from replicating, while Emtricitabine and Tenofovir Alafenamide are nucleoside reverse transcriptase inhibitors that block the reverse transcriptase enzyme that the virus needs to reproduce. These tablets are commonly used in the management of HIV infection and can be taken with or without food. It is important to take the tablets at the same time every day to achieve optimal results.

FAQs of Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets:

Q: What is the recommended dosage for Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets?

A: The recommended dosage for these tablets depends on the severity of the HIV infection and the patients medical history. It is important to follow the dosage instructions provided by the healthcare provider.

Q: How should Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets be stored?

A: These tablets should be stored in a dry place away from direct sunlight and moisture. It is important to keep the tablets out of reach of children.

Q: Can these tablets be taken with other medications?

A: It is important to inform the healthcare provider of any other medications being taken, as they may interact with Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets.

Q: Are there any side effects associated with these tablets?

A: Some of the common side effects associated with these tablets include headache, nausea, diarrhea, and fatigue. It is important to inform the healthcare provider of any unusual side effects.

Q: Can these tablets cure HIV?

A: While Dolutegravir Emtricitabine Tenofovir Alafenamide Tablets can help manage HIV infection, they cannot cure the disease. It is important to continue taking the tablets as prescribed by the healthcare provider.

Tell us about your requirement